ResearcherGarvan Institute of Medical ResearchActive in the last 2 years
Lily M. Channon
Matched on ORCID iD 0000-0002-4456-4233; OpenAlex author ID A5049279344. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 3
- Pulsed priming with the FAK inhibitor narmafotinib enhances both gemcitabine/Abraxane and FOLFIRINOX chemotherapy response in pancreatic cancer Co-author DOI 10.64898/2026.07.23.740234↗
- Targeting the NPY/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasis. Co-author DOI 10.1126/sciadv.adq4416↗
- Small extracellular vesicles (exosomes) and their cargo in pancreatic cancer: Key roles in the hallmarks of cancer. Co-author DOI 10.1016/j.bbcan.2022.188728↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zhihong Xu · 1 shared paper, 2022 · strength 0.17
- Minoti Vivek Apte · 1 shared paper, 2022 · strength 0.17
- Jeremy S. Wilson · 1 shared paper, 2022 · strength 0.17
- Chamini Jayamali Perera · 1 shared paper, 2022 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.